| Literature DB >> 27940603 |
Xi Li1, Shuangqing Li1, Shenghua Xiong2, Zhujun Wang3, Hu Zhang4.
Abstract
Plexiform angiomyxoid myofibroblastic tumor (PAMT) is a rare gastric mesenchymal entity with a peculiar plexiform pattern, bland spindle cells and myxoid stroma rich in arborizing blood vessels. Here we report a 44-year-old Chinese woman with PAMT. Initially she was admitted for removal of a gastric antral'polyp' found on a routine examination 5 months previously. Our gastroscopy showed a 0.8 × 0.8 cm polyp-like mass in the antrum which protruded into the lumen. Endoscopic submucosal dissection (ESD) was performed to remove this mass en bloc. The specimen was carefully examined by pathologists, and the correct diagnosis of PAMT was finally made. The tumor in this case depicted typical histopathological and immunohistochemical features of gastric PAMT. This PAMT was not only the smallest on endoscopic examination in the literature but also-unlike the already reported PAMTs-exhibited a focal hyperechogenic lesion on endoscopic ultrasonography (EUS). This information highlights its value on how to identify a PAMT at its early stage.Entities:
Keywords: diagnosis; endoscopic ultrasonography; gastrointestinal stromal tumors; plexiform angiomyxoid myofibroblastic tumor
Year: 2016 PMID: 27940603 PMCID: PMC6225817 DOI: 10.1093/gastro/gow035
Source DB: PubMed Journal: Gastroenterol Rep (Oxf)
Figure 1.Endoscopic and endosonographic views of the plexiform angiomyxoid myofibroblastic tumor (PAMT) at the antrum of the stomach. (A) Endoscopic view of the tumor showing a 0.8 × 0.8 cm polyp-like mass; (B) Endosonographic image showing homogeneous hyperechoic lesion protruding into the lumen (indicated by arrows).
Figure 2.Pathological findings of the plexiform angiomyxoid myofibroblastic tumor (PAMT). (A) Multinodular plexiform growth pattern (hematoxylin-eosin staining, ×40); (B) Multinodular plexiform pattern with bland spindle tumor cells (red arrow), myxoid extracellular matrix and fine arborizing vessels (blue arrow) (hematoxylin-eosin staining, ×200); (C) Diffusely positive staining for vimentin (immunohistochemical staining, ×200); (D) Diffusely positive staining for CD34 (immunohistochemical staining, ×200); (E) Negative staining for SMA (immunohistochemical staining, ×200); (F) Negative staining for CD177 (immunohistochemical staining, ×200).